BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 6300166)

  • 1. Nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function.
    Pang S; Levine LS; Stoner E; Opitz JM; Pollack MS; Dupont B; New MI
    J Clin Endocrinol Metab; 1983 Apr; 56(4):808-18. PubMed ID: 6300166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic-pituitary-gonadal axis function in pubertal male and female siblings with glucocorticoid-treated nonsalt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia.
    Chang YT; Kulin HE; Garibaldi L; Suriano MJ; Bracki K; Pang S
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1251-7. PubMed ID: 8077318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Male pseudohermaphroditism due to nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency: gender role change and absence of gynecomastia at puberty.
    Mendonca BB; Bloise W; Arnhold IJ; Batista MC; Toledo SP; Drummond MC; Nicolau W; Mattar E
    J Steroid Biochem; 1987 Dec; 28(6):669-75. PubMed ID: 2826919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency.
    Rhéaume E; Sanchez R; Simard J; Chang YT; Wang J; Pang S; Labrie F
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1012-8. PubMed ID: 7962268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of 3 beta-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated delta 5-steroid levels.
    Sakkal-Alkaddour H; Zhang L; Yang X; Chang YT; Kappy M; Slover RS; Jorgensen V; Pang S
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3961-5. PubMed ID: 8923844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New studies of the 11 beta-hydroxylase and 18-hydroxylase enzymes in the hypertensive form of congenital adrenal hyperplasia.
    Levine LS; Rauh W; Gottesdiener K; Chow D; Gunczler P; Rapaport R; Pang S; Schneider B; New MI
    J Clin Endocrinol Metab; 1980 Feb; 50(2):258-63. PubMed ID: 6243663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zona glomerulosa function after life-long suppression in two siblings with the hypertensive virilizing form of congenital adrenal hyperplasia.
    Rodríguez Portales JA; Arteaga E; López Moreno JM; Biglieri EG
    J Clin Endocrinol Metab; 1988 Feb; 66(2):349-54. PubMed ID: 3276723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency.
    Lutfallah C; Wang W; Mason JI; Chang YT; Haider A; Rich B; Castro-Magana M; Copeland KC; David R; Pang S
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2611-22. PubMed ID: 12050224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia.
    Zhang L; Sakkal-Alkaddour H; Chang YT; Yang X; Pang S
    J Clin Endocrinol Metab; 1996 Jan; 81(1):291-5. PubMed ID: 8550766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
    Barnes RB; Ehrmann DA; Brigell DF; Rosenfield RL
    J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild adrenal 3 beta-hydroxysteroid dehydrogenase deficiency with hyperaldosteronism.
    Hashimoto K; Makino S; Takao T; Sugawara M; Suemaru S; Ota Z
    Endocrinol Jpn; 1988 Oct; 35(5):675-83. PubMed ID: 3220046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.
    Pang SY; Lerner AJ; Stoner E; Levine LS; Oberfield SE; Engel I; New MI
    J Clin Endocrinol Metab; 1985 Mar; 60(3):428-39. PubMed ID: 2982896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal ovarian function in a mild form of late-onset 3 beta-hydroxysteroid dehydrogenase deficiency.
    Medina M; Herrera J; Flores M; Martin O; Bermúdez JA; Zárate A
    Fertil Steril; 1986 Dec; 46(6):1021-5. PubMed ID: 3023147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new inherited variant of the 3 beta-hydroxysteroid dehydrogenase-isomerase deficiency syndrome: evidence for the existence of two isoenzymes.
    Cravioto MD; Ulloa-Aguirre A; Bermudez JA; Herrera J; Lisker R; Mendez JP; Perez-Palacios G
    J Clin Endocrinol Metab; 1986 Aug; 63(2):360-7. PubMed ID: 3088022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche.
    Lucky AW; Rosenfield RL; McGuire J; Rudy S; Helke J
    J Clin Endocrinol Metab; 1986 May; 62(5):840-8. PubMed ID: 3007557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency.
    Simard J; Rhéaume E; Sanchez R; Laflamme N; de Launoit Y; Luu-The V; van Seters AP; Gordon RD; Bettendorf M; Heinrich U
    Mol Endocrinol; 1993 May; 7(5):716-28. PubMed ID: 8316254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma 3 beta-hydroxy-delta 5-steroids in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Young J; Couzinet B; Pholsena M; Nahoul K; Labrie F; Schaison G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):299-304. PubMed ID: 8106615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and functional characterization of the novel missense mutation Y254D in type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene of a female patient with nonsalt-losing 3 beta HSD deficiency.
    Sanchez R; Rhéaume E; Laflamme N; Rosenfield RL; Labrie F; Simard J
    J Clin Endocrinol Metab; 1994 Mar; 78(3):561-7. PubMed ID: 8126127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of molecular defect in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta-HSD activity.
    Chang YT; Zhang L; Alkaddour HS; Mason JI; Lin K; Yang X; Garibaldi LR; Bourdony CJ; Dolan LM; Donaldson DL
    Pediatr Res; 1995 Jun; 37(6):820-4. PubMed ID: 7651769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Male pseudohermaphroditism caused by nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) deficiency.
    Heinrich UE; Bettendorf M; Vecsei P
    J Steroid Biochem Mol Biol; 1993 Apr; 45(1-3):83-5. PubMed ID: 8481355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.